[1]
Sussman, G., Hebert, J., Gulliver, W., Lynde, C., Lang, W.H., Chambenoit, O., Deutsch, G., DeTakaosy, F. and Rihakova, L. 2018. Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S51. DOI:https://doi.org/10.25251/skin.2.supp.51.